ozempic semaglutide rash Doctors explain what's behind skin itch, plus what to do if you experience it rash with semaglutide rash at

Description

Potential risks include: Enhanced gastrointestinal side effects (nausea, vomiting, diarrhea, constipation) Increased risk of nutritional deficiencies and protein malnutrition Potential worsening of gastroesophageal reflux symptoms Dehydration risk and acute kidney injury, particularly during dose escalation Increased risk of gallbladder disease and complications Risk of intestinal obstruction or ileus Diabetic retinopathy progression in patients with diabetes, particularly with rapid glycemic improvement Hypoglycemia risk, particularly in patients on insulin or sulfonylureas Cost considerations and insurance coverage challenges Rare but serious risks including pancreatitis and thyroid C-cell tumors (boxed warning) Clinicians must engage in shared decision-making with patients, carefully weighing these potential benefits against risks in the context of individual patient circumstances, surgical outcomes, comorbidities, and treatment goals

Retatrutide as a Novel Treatment for Obesity and Type 2 Diabetes

The Food and Drug Administration (FDA) has approved several weight-loss medications, also known as anti-obesity medications, that may help some people with type 2 diabetes and overweight or obesity manage their weight

For many people whove lived with food noise for a long time, theres now research explaining why it happens

Genetic Predispositions and Individual Discontinuation Risk Genetic variants in GLP1R (rs6923761), FTO (rs9939609), and MC4R (rs17782313) pathways may predict metabolic resilience and rebound susceptibility